Pleural Effusions After Cardiac Surgery
Pleural Effusions Are Associated With Adverse Outcomes After Cardiac Surgery
1 other identifier
observational
11,198
1 country
1
Brief Summary
Pleural effusions occur commonly in patients recovering from cardiac surgery, however, the impact on outcomes is not well characterized. The purpose of this study is to characterize the outcomes of cardiac surgery patients with pleural effusions. All patients undergoing cardiac surgery between 2006 and 2019 were included in this observational, cross-sectional analysis using propensity matching.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2006
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2006
CompletedFirst Submitted
Initial submission to the registry
January 18, 2018
CompletedFirst Posted
Study publicly available on registry
January 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedJune 9, 2021
June 1, 2021
14 years
January 18, 2018
June 7, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
mortality
In-Hospital mortality
an average of 30 days
hospital stay
Length of hospital stay
an average of 30 days
Secondary Outcomes (5)
Need of drainage
an average of 30 days
extubation
an average of 15 hours
renal replacement
an average of 30 days
transfusions
an average of 30 days
ICU stay
an average of 15 days
Study Arms (3)
Group 0
patients without pleural effusion
Group 1
patients with pleural effusion
Group 2
patients with pleural Effusion and need of drainage
Eligibility Criteria
All adult male and female patients who have undergone cardiac surgery in the period 01/06-12/19 at Campus Mitte in the Charité, approx. 11,000 patients.
You may qualify if:
- In-patients of the Charité Universitätsmedizin Berlin
- at least 18 years old
- female or male sex
- cardiosurgical intervention (OPS 5.35 and 5.36) between 01/06 and 12/19
- post-operative monitoring in the intensive care unit
You may not qualify if:
- previous cardiosurgical interventions during the same hospital stay
- incomplete documentation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charité - Universitaetsmedizin Berlin
Berlin, 10117, Germany
Related Publications (1)
Schiefenhovel F, Poncette AS, Boyle EM, von Heymann C, Menk M, Vorderwulbecke G, Grubitzsch H, Treskatsch S, Balzer F. Pleural effusions are associated with adverse outcomes after cardiac surgery: a propensity-matched analysis. J Cardiothorac Surg. 2022 Dec 7;17(1):298. doi: 10.1186/s13019-022-02050-y.
PMID: 36476289DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Felix Balzer, MD, MSc, PhD
Charite Universitätsmedizin Berlin
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. med. Dr. rer. nat., MSc
Study Record Dates
First Submitted
January 18, 2018
First Posted
January 24, 2018
Study Start
January 1, 2006
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
June 9, 2021
Record last verified: 2021-06